Sort
23,748 grants matching “melanoma”
Combinatorial Approaches to Overcoming Resistance to BRAF(V600E) Targeted Thera
$193,972David E Fisher · Massachusetts General Hospital · P01 · FY2014 · CA
PHASE I TRIAL OF INTERLEUKIN 12 FOLLOWED BY INTERFERON
$193,916Ohio State University · M01 · FY2001 · RR
Machine Learning Tools for Prognostication in Melanoma
$193,798Mousumi Banerjee · University Of Michigan At Ann Arbor · R21 · FY2011 · CA
HUMAN
$193,796Ellen L Jones · Duke University · P01 · FY2007 · CA
Targeting metabolic checkpoints in the tumor microenvironment to boost efficacy of anti-CTLA-4
$193,793Lewis Zhichang Shi · University Of Alabama At Birmingham · R21 · FY2019 · CA
Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
$193,793John M Parant · University Of Alabama At Birmingham · R21 · FY2017 · CA
Molecular Regulation of Human Melanoma Metastasis
$193,787Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2006 · CA
TUMOR-TARGETING WITH NEW BORONATED PORPHYRINS
$193,787Maria Da Graca Henriques Vicente · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2006 · CA
MARSHALL U COBRE: B-CATENIN FUNCTION AND RETINOIC ACID IN MELANOMA
$193,761Marshall University · P20 · FY2004 · RR
Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients
$193,715Mayer Fishman · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · FD
'Arresting' bone marrow T cell sequestration in patients with GBM
$193,676Peter Fecci · Duke University · P50 · FY2021 · CA
Hepatitis C viral sensing by non-parenchymal liver cells (NPC)
$193,646Hugo R Rosen · University Of Colorado Denver · R21 · FY2014 · AI
Investigating the mechanism of K17-mediated immunosuppression in papillomavirus-induced cancers
$193,616Wei Wang · Henry Ford Health + Michigan State University Health Sciences · K22 · FY2024 · CA
Investigating the mechanism of K17-mediated immunosuppression in papillomavirus-induced cancers
$193,616Wei Wang · Henry Ford Health + Michigan State University Health Sciences · K22 · FY2025 · CA
A statistical framework to systematically characterize cancer driver mutations in noncoding genomic regions
$193,576Eliezer M Van Allen · Dana-Farber Cancer Inst · R21 · FY2020 · CA
Administrative Core
$193,575Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA
Core B: Biospecimen Core
$193,550Ruth Halaban · Yale University · P50 · FY2023 · CA
Anti-angiogenesis targeted vaccine therapy
$193,479Samir Khleif · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Administration, Evaluation and Planning Core
$193,472Thomas S. Kupper · Brigham And Women'S Hospital · P50 · FY2011 · CA
Role of CD44 in EC injury and melanoma therapy
$193,469Virginia Commonwealth University · R01 · FY2005 · AI
Clinical Research
$193,437Richard M Goldberg · Univ Of North Carolina Chapel Hill · P30 · FY2011 · CA
Perioperative Targeted Genotyping in Glioma
$193,298Ganesh Shankar · Massachusetts General Hospital · K08 · FY2023 · NS
Perioperative Targeted Genotyping in Glioma
$193,298Ganesh Shankar · Massachusetts General Hospital · K08 · FY2021 · NS
Perioperative Targeted Genotyping in Glioma
$193,298Ganesh Shankar · Massachusetts General Hospital · K08 · FY2019 · NS
Perioperative Targeted Genotyping in Glioma
$193,298Ganesh Shankar · Massachusetts General Hospital · K08 · FY2020 · NS